Optimal Velocity and Safety of Discontinuous Conduction through the Heterogeneous Purkinje-Ventricular Junction  by Aslanidi, Oleg V. et al.
20 Biophysical Journal Volume 97 July 2009 20–39Optimal Velocity and Safety of Discontinuous Conduction through
the Heterogeneous Purkinje-Ventricular Junction
Oleg V. Aslanidi,† Philip Stewart,† Mark R. Boyett,‡ and Henggui Zhang†*
†Biological Physics Group, School of Physics and Astronomy, and ‡Cardiovascular Research Group, Faculty of Medical and Human Sciences,
University of Manchester, Manchester, United Kingdom
ABSTRACT Slow and discontinuous wave conduction through nonuniform junctions in cardiac tissues is generally considered
unsafe and proarrythmogenic. However, the relationships between tissue structure, wave conduction velocity, and safety at such
junctions are unknown. We have developed a structurally and electrophysiologically detailed model of the canine Purkinje-
ventricular junction (PVJ) and varied its heterogeneity parameters to determine such relationships. We show that neither very
fast nor very slow conduction is safe, and there exists an optimal velocity that provides the maximum safety factor for conduction
through the junction. The resultant conduction time delay across the PVJ is a natural consequence of the electrophysiological
and morphological differences between the Purkinje ﬁber and ventricular tissue. The delay allows the PVJ to accumulate and
pass sufﬁcient charge to excite the adjacent ventricular tissue, but is not long enough for the source-to-load mismatch at the junc-
tion to be enhanced over time. The observed relationships between the conduction velocity and safety factor can provide new
insights into optimal conditions for wave propagation through nonuniform junctions between various cardiac tissues.INTRODUCTION
Propagation of electrical excitation waves—action potentials
(APs)—is the basis for fast signal transmission that triggers
synchronized muscle contractions in the heart (1,2). To
maintain normal cardiac function, APs must be rapidly and
safely conducted through the whole conduction pathway of
the heart, consisting of both simple cablelike structures and
complex heterogeneous tissues that are often formed by cells
with varying morphology, electrical excitability, and inter-
cellular coupling. AP conduction velocity is determined
primarily by the latter two factors (3), but is also influenced
by the presence of structural heterogeneities within the tissue
(4–8). Such heterogeneities can create a local electrical
source-to-load mismatch—a misbalance between the current
provided by a smaller mass of tissue (source) and the current
necessary to bring to threshold an adjacent larger mass of
tissue (load). Source-to-load mismatch can induce a local
slowing of conduction, or even a conduction failure (4–12).
Hence, along with reduced excitability and reduced inter-
cellular coupling, source-to-load mismatch at junctions
between different cardiac tissues can contribute to slow,
discontinuous, and potentially unsafe AP conduction in the
heart.
The Purkinje-ventricular junction (PVJ) is a typical
cardiac junction with structural and electrophysiological
heterogeneities, where source/load mismatch and discontin-
uous conduction can occur. Under normal conditions,
APs conducted from thin Purkinje fibers (PF) into the large
mass of ventricles determine electrical activation and con-
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uous conduction through the heterogeneous PVJ can be
arrhythmogenic. Primarily, discontinuities in the AP con-
duction velocity, commonly manifested experimentally as
conduction time delays at the PVJ (9–14), have long been
considered indicative of unsafe conduction leading to
possible conduction blocks (9–12) or reentry (13). Slow
AP conduction and associated time delays have also been
linked with arrhythmogenic substrate in other (healthy or
infarcted) cardiac tissues (7,15–17). However, other experi-
mental studies have provided evidence for greater safety
with slow conduction (18)—under certain conditions, the
safety factor may increase with slow conduction instead of
decreasing. A modeling study with one-dimensional cardiac
tissue (3) has suggested that the dependence of the safety
factor on conduction velocity can be biphasic within the
same system, where safety sharply decreases only at very
slow velocities. However, precise relationships between
tissue heterogeneities (both structural and functional), the
AP conduction velocity, and measures of the risks of
conduction failure remain unclear.
The aim of this study is to determine such relationships
using a detailed computer model of AP conduction through
the PVJ that accounts for both electrophysiological and
morphological differences between PFs and the ventricles.
Thus, we first develop a new biophysically detailed AP
model for a canine PF cell by modifying an existing canine
ventricular cell model (19,20) based on extant voltage-clamp
datasets recorded for major ionic currents from canine PF
cells (21). Then, a three-dimensional (3D) wedge model of
the canine PVJ is developed based on an earlier diffusion-
tensor MRI reconstruction (20), which incorporates details
of the transmural AP heterogeneity, tissue geometry, and
fiber orientation of the canine left ventricular free wall.
doi: 10.1016/j.bpj.2009.03.061
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the endocardium. The resultant model is used to study the
relationships between the tissue heterogeneity, the AP
conduction velocity, and the safety factor (3) at the PVJ.
MODEL DEVELOPMENT
The dynamics of electrical waves in cardiac tissues can be
described by the following reaction-diffusion-type nonlinear
partial differential equation (19,20):
vV
vt
¼ V$DVV  Iion
Cm
: (1)
Here, V (mV) is the transmembrane potential, t is time (s),
and V is a spatial gradient operator defined within the tissue
geometry. D is a tensor of diffusion coefficients (mm2 ms1)
that characterizes electrotonic intercellular spread of voltage
via gap junctional coupling, Cm (pF) is the cell membrane
capacitance, and Iion is the total membrane ionic current
(pA). Biophysically detailed models have been developed
previously to describe the voltage- and time-dependent
current Iion, and hence cell-specific AP properties, in canine
ventricles (20).
Single PF cell model
We develop a detailed description of Iion, and hence a single-
cell AP, for canine PF cells by modifying the existing canine
endocardial cell model (20) based on experimental data for
the kinetics of several major ionic currents in canine PFs
(21). These include the L-type and T-type Ca2þ currents,
ICa,L and ICa,T, the transient outward current, Ito, the fast
and slow delayed rectifier currents, IK,r and IK,s, and the
inward rectifier Kþ current, IK,1. Conductances and kinetics
of each of the currents in the canine endocardial cell model
(20) were modified to simulate their correct current/voltage
(I/V) relationships and time courses, as recorded experimen-
tally from canine PF cells (21). Below, we describe details of
such modifications made for each individual current.
Fast Naþ current, INa
Maximum conductance, gNa, and the time constant for the
slow component of inactivation, tj, in the PF cell model
were reduced to 66% and 10%, with respect to the values
for the endocardial cell model (20) to produce an AP upstroke
velocity comparable to experimental data (Table 1). Relative
contributions of the fast, h, and slow, j, components of inacti-
vation were set to 80% and 20%, respectively.
Late Naþ current, INa,L
This current has a greater effect on the AP duration in PF
cells than in ventricular cells (22,23). We used characteristics
of INa,L recorded from canine PFs (24) to modify its descrip-
tion in the canine endocardial cell model (20). This included
a 22 mV shift in the steady-state inactivation curve, hL,N,and reformulation of the inactivation time constant, th,L, as
a variable. Maximum conductance, gNa,L, was rescaled based
on the measured I/V relationship for INa,L (24). The value of
gNa,L in the PF cell model was fivefold larger compared to
that in the endocardial cell model. Experimentally validated
characteristics of this current are presented in Fig. 1. As
a result of the modification, the AP duration in the PF was
significantly increased in comparison to that in ventricular
cells (25).
L-type Ca2þ current, ICa,L
Kinetics of fast and slow voltage-dependent inactivation
variables, f and f2, were refit to experimental data (21):
sigmoid steady-state inactivation curves and time constants
were modified based on experimentally measured values
of their half-inactivation and slope factors (Fig. 2). The
maximum conductance, gCa,L, was determined by fitting
the simulated I/V relationship for ICa,L to experimental data
(21). This resulted in 66% reduction in gCa,L compared to
the respective value for the endocardial cell model (20). As
a result, the AP duration in the PF was significantly increased
and the AP plateau was lowered in comparison to ventricular
cells (25).
T-type Ca2þ current, ICa,T
This current is absent in the ventricular cell model (20), but is
recorded from canine PF cells (21). Hence, we incorporated
ICa,T into the PF cell model (Fig. 3). Sigmoid expressions for
steady-state activation (b) and inactivation (g) were derived
from the experimental data (21). Expressions for the time
constants of activation and inactivation were taken from
a rabbit sinoatrial cell model (26). The resultant equations
and parameters used (such as maximum channel conduc-
tance, gCa,T were validated by matching the simulated I/V
relationship for ICa,T to the experimental data (21), as shown
in Fig. 3 C. The introduction of ICa,T contributed to the
experimentally observed increase of the AP duration with
respect to ventricular cells (25).
Transient outward Kþ current, Ito,1
Expression for the steady-state activation variable, aN, was
fitted to experimental data (21), which resulted in a 36-mV
TABLE 1 Action potential properties in a canine PF cell: model
versus experiment
Han et al.
(21)
Dumaine et al.
(23)
Kondo et al.
(25) Simulation
RP, mV 80 83 85 83
APA, mV 112 120 115 124
PP, mV 3 10 – 7
APD, mV 373 – 378 375
_Vmax, V/s – – 250 262
RP, resting potential; APA, action potential amplitude; PP, plateau potential;
APD, action potential duration; _Vmax, maximum upstroke velocity. In both
the model and experiments, APD was measured at 90% repolarization after
periodic pacing at 1 Hz.Biophysical Journal 97(1) 20–39
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FIGURE 1 Model of the late Naþ current, INa,L. Here,
and in Figs. 2–6, simulated curves (lines) are compared to
respective experimental data (circles) (24). (A) Steady-state
inactivation curve. (B) Inactivation time constant. (C) INa,L
during 500-ms voltage-clamp pulses to 70 to þ30 mV
from the holding potential of 80 mV. (D) I/V relationship.
Vtest, test voltage.shift in the half-activation compared to the respective expres-
sion in the endocardial cell model. In addition, expression for
the activation time constant, ta, was also shifted by 36 mV.
Both fast and slow inactivation variables, i and i2, were refit-ted to the experimental data (21) by modifying their respec-
tive half-inactivation and slope factors and time constants
(Fig. 4). Relative contributions of the inactivation compo-
nents i and i2 were set to 80% and 20%, respectively.BA
C D
FIGURE 2 Model of the L-type Ca2þ current, ICa,L
compared with experimental data (21). (A) Steady-state acti-
vation and inactivation curves. (B) Fast and slow voltage-
dependent inactivation time constants, t1 and t2. (C) ICa,L
during 200-ms voltage-clamp pulses to 40 to þ50 mV
from a holding potential of 50 mV. (D) I/V relationship.
Biophysical Journal 97(1) 20–39
Safety of Discontinuous Conduction 23Maximum conductance, gto,1, was determined by fitting the
simulated I/V relationship for Ito,1 to the experimental data
(21). The resultant value of gto,1 in the PF cell model was
49% larger than in the endocardial cell model. Modifications
B
C
A
FIGURE 3 Model of the T-type Ca2þ current, ICa,T compared with exper-
imental data (21). (A) Steady-state activation and inactivation curves. (B)
ICa,T during 200-ms voltage-clamp pulses to 70 to þ40 mV from a holding
potential of 90 mV. (C) I/V relationship.to Ito,1 changed the morphology of the AP notch and the
plateau of the PF cell, providing better correspondence to
experimental data (25).
Inward rectiﬁer Kþ current, IK,1
To fit the steady-state I/V relationship for IK,1 to experi-
mental data (21), the maximum conductance, gK,1, was
rescaled, and a small constant component was added to the
steady-state activation (see the Appendix). The resultant
value of gK,1 in the PF cell model was 50% of the respective
value in the endocardial model.
Rapid delayed rectiﬁer Kþ current, IK,r
Equations of IK,r were modified based on experimental data
(21). The steady-state activation curve, xr,N, was shifted by
10 mV and its slope factor increased by 288%; the
steady-state inactivation curve, rr,N, was shifted by
15.4 mV and its slope factor increased by 132% (Fig. 5);
and activation and inactivation time constants, tx,r and tr,r,
were reformulated based on Hodgkin-Huxley formalism.
The maximum conductance, gK,r, was determined from the
measured current density of IK,r (21). The resultant value of
gK,r was ~163% larger in the PF cell model compared to the
endocardial cell. Model equations and parameters were
validated by matching the simulated I/V relationship for IK,r
to the experimental data (21) for both the step and tail currents.
Slow delayed rectiﬁer Kþ current, IK,s
To match experimental data (21), the steady-state activation
curve, xs,N, was shifted by 1.5 mV and its slope factor
decreased to 55% (Fig. 6). The maximum conductance,
gK,s, was determined by fitting the simulated I/V relationship
for IK,s to the experimental data (21). The resultant value of
gK,s was ~135% larger than in the endocardial cell model.
Changes in IK,1, IK,r, and IK,s contributed to producing the
correct AP morphology at repolarization stages (25).
Detailed equations and parameters for the newly devel-
oped canine PF cell model are presented in the Appendix
(the respective code in C is available on request). Figs. 7–9
summarize the results of the single PF cell model develop-
ment. Fig. 7 illustrates differences in current densities
between the canine PF cell and three ventricular cell types:
major differences are seen in INa,L, IK,r, and IK,1, which
contribute to large differences in the AP plateau, duration,
and repolarization properties between these cells. Fig. 8 illus-
trates dynamic differences in APs and ionic currents between
the canine PF and ventricular cell models, and Fig. 9 vali-
dates the resultant AP morphology and rate dependence in
the canine PF cell model. The AP shape and duration, as
well as the full AP duration (APD) restitution curve, are in
good agreement with experimental data (25,27), which vali-
dates the model equations and parameters used. A full
comparison of the AP characteristics in PF cells between
our simulations and experimental data is shown in Table 1.
Biophysical Journal 97(1) 20–39
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FIGURE 4 Model of the transient outward Kþ current,
Ito,1, compared to experimental data (21). (A) Steady-state
activation and inactivation curves. (B) Fast and slow
voltage-dependent inactivation time constants, tfast and
tslow,; (C) Ito during 100-ms voltage-clamp pulses to 40
to þ70 mV from a holding potential of 70 mV. (D) I/V
relationship. Note that D shows the pure four-AP-sensitive
current Ito,1, whereas C presents the sum of Ito,1 and the
steady-state component of the outward Kþ current, Ito,2.3D tissue model
The ventricular and PF single-cell models were incorporated
into a 3D tissue model describing the detailed anatomical
structure of the canine ventricles (20).
The 3D ventricular wedge geometry was represented by
a regular Cartesian grid of 50  50  50 points (‘‘cells’’)
with a resolution of 0.35 mm; for each point, a flag variable
identified whether it belonged to the endocardial, midmyocar-
dial, or epicardial layer (20). A single PF strand consisting of
50 ‘‘cells’’ entered the wedge perpendicular to the endocardial
surface. Values of the diffusion coefficients characterizing
electrotonic coupling along and transverse to ventricular
fibers, Djj ¼ 0.60 mm2 ms1 and Dt ¼ 0.15 mm2 ms1,
were chosen to reproduce experimentally observed aniso-
tropic AP conduction velocities in the canine ventricles
(20). The value of the diffusion coefficient characterizing
electrotonic coupling along the quasi-one-dimensional PF
strand was chosen to produce the experimentally observed
velocity of ~1.8 m/s (28). Combinations of the fiber orienta-
tion vectors and the diffusion coefficients gave components
of the tensor D at each grid point (19).
Equation 1 was solved on the geometry grid using a finite-
difference partial differential equation (PDE) solver based on
the explicit Euler method with time and space steps, Dt ¼
0.01 ms and Dx¼ 0.35 mm, respectively. Note that the space
step of 0.35 mm corresponds to the spatial resolution of the
diffusion tensor MRI data on which canine ventricular geom-
etry has been based; the geometry has been successfully used
Biophysical Journal 97(1) 20–39to simulate transmural propagation in canine ventricles (20).
However, to study possible effects of spatial resolution
on simulation results, we have reduced the space step to
0.175 mm by introducing intermediate points between the
existing grid points and linearly interpolating fiber orienta-
tions. Results of simulations with this refined model were
in agreement with those using the original space step. A
computer code implementing the PDE solver was parallel-
ized under MPI and executed on the Horace supercomputer
(Manchester, UK). A single run of the code simulating 1 s of
activity on eight CPUs took ~45 min. Thus, a high-resolution
model incorporating detailed tissue anatomy, fiber orienta-
tion, and electrical heterogeneity within the canine PVJ has
been constructed and implemented.
2D slice model
We have also studied a simple 2D model of the PVJ with a PF
strand connected to a 2D caricature of a transmural slice of
ventricular tissue with realistic dimensions and couplings.
Note that such a model provides a feasible description for
the transmural AP propagation (20). Geometry of the 2D
model is illustrated in Fig. 10 A. Dimensions of the tissue
were varied along the horizontal spatial coordinate, x, with
the vertical width of the PF, d1, smaller than the width of
the ventricular slab, d2 (10,14). The thickness of the ventric-
ular tissue was 17.5 mm, with endocardial, midmyocardial,
and epicardial regions occupying one third each (20). The
diffusion coefficient, D, was also defined as a spatially
Safety of Discontinuous Conduction 25nonuniform function of x (Fig. 10B), with higher values in the
PF than in ventricular tissues, D1 > D2 (28). In control simu-
lations, parameter values were d1 ¼ 0.7 mm, d2 ¼ 17.5 mm,
D1 ¼ 0.8 mm2 ms1, and D2 ¼ 0.2 mm2 ms1. The model
produced AP conduction velocities of 1.8 m/s and 0.5 m/s
in the PF and ventricular tissues, respectively, as observed
experimentally (28,29). As the coupling decreased and the
tissue dimensions increased between the PF and the ventricle,
the AP conduction through the PVJ was discontinuous, with
a time delay,DT, of up to ~7.5 ms (Fig. 10C), as seen in exper-
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FIGURE 5 Model of the fast delayed rectifier Kþ current, IK,r. (A) IK,r
simulated during 1000 ms voltage-clamp pulses to 40 to þ50 mV from
a holding potential of 50 mV, followed by a repolarizing 1000 ms pulse
to 30 mV; B and (C) simulated I/V relationships for the step (B) and
tail (C) currents compared to the respective experimental data (21).iments (10,28). It is important to note that the discontinuity
was due to the natural nonuniformity of the PVJ and did not
require a specific resistive barrier (5,14).
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FIGURE 6 Model of the slow delayed rectifier Kþ current, IK,s, compared
to the respective experimental data (21). (A) IK,s during 5000-ms voltage-
clamp pulses to 40 to þ60 mV from a holding potential of 60 mV,
followed by a repolarizing 500-ms pulse to 40 mV. (B and C) I/V relation-
ships for the step (B) and tail (C) currents.
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FIGURE 7 Differences in ionic current densities between
canine ventricular cell models (20) and our model for the
canine PF cell. Currents are indicated by open vertical
bars. Circles indicate experimentally measured values of
the respective current densities in PF cells (21,24).
ENDO, endocardial cell; M, midmyocardial cell; EPI,
epicardial cell.Safety factor
The safety factor (SF) has been introduced as a simple index
of the robustness of conduction in cardiac tissues (3,30). It is
defined as the ratio of charge generated to charge consumed
by a cell during its excitation. SF > 1 indicates successful
conduction, with its fraction of >1 representing the margin
of safety. When SF is close to 1, conduction is critical, and
when SF < 1, propagation fails. The equation used to
compute SF is
SF ¼
R
A
Icdt þ
R
A
IoutdtR
A
Iindt
;Ajt˛½t1%; tVmax : (2)
Here, Ic is the capacitive current of the cell, Iout is the inter-
cellular current that flows from the cell to its downstream
neighbor, and Iin is the intercellular current that flows
into the cell from its upstream neighbor. The domain of inte-
gration, A, can be defined as the period of time from the
moment when dV / dt at the AP wavefront reaches 1% of
its maximum to the moment when V reaches its maximum,
Vmax (30). Note that Ic ¼ vV / vt, Iin ¼ DVV- , and Iout ¼
DVVþ (with all currents normalized by the membrane
capacitance, Cm).
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Simulations with the 2D slice model were carried out first to
establish relationships between parameters of the tissue
heterogeneity (primarily dimensions, d, and diffusion coeffi-
cient, D) and the AP conduction velocity and safety factor at
the PVJ. Similar simulations were then carried out in the full
3D model to verify the results obtained.
2D slice simulations
As described above, parameters d1 < d2 and D1 > D2 were
adjusted to experimentally validated values, which repro-
duced experimentally observed AP conduction velocities in
the PF and ventricular tissues. Under such physiological
conditions, AP conduction through the morphologically
and electrically nonuniform PVJ was discontinuous, with
a sharp increase in the conduction time delay, DT, measured
over 2 mm along the x-direction. When both morphological
and intercellular coupling heterogeneities were considered,
the maximum measured DT was ~7.5 ms at the PVJ
(Fig. 10), consistent with experimental measurements of
3–10 ms (9–14). When heterogeneity in the tissue dimen-
sions was considered alone (d1 < d2, D1 > D2), the
maximum time delay, DT, at the PVJ was ~4 ms. When
Safety of Discontinuous Conduction 27heterogeneity in the intercellular coupling was considered
alone (d1 ¼ d2, D1 > D2,), DT was ~4.5 ms (Fig. 11 A).
Without nonuniformities in the tissue dimensions or
coupling, AP conduction was continuous (i.e., no significant
time delay was observed), even though the electrophysiolog-
ical properties of the PF and ventricular cells were different.
As DT increased, the AP conduction velocity at the PVJ,
v, decreased from ~1.3 m/s in the uniform tissue (d1 ¼ d2,
D1 > D2,) to ~0.2 m/s in the tissue with nonuniformities in
d and D (Fig. 11 B). Note that local velocity decreases at
nonuniform tissue junctions has been explained by
mismatches between the electrical current source and load
(4–8), and are generally considered proarrythmogenic
(7,9–13), but precise relationships between the conduction
velocity and safety have not been established.
The AP conduction through the PVJ and the associated SF
are shown in Fig. 12: under physiological conditions (as
defined above), the conduction delay resulted in a local increase
in the SF around the PVJ, which can be explained by an accu-
mulation of charge at the PVJ due to source/load mismatch.
Below we describe qualitative relationships between the SF
and the conduction velocity through the PVJ, v, arising under
variations of the tissue heterogeneity parameters.
Changes in velocity v can be achieved by varying either the
width (d1) or the diffusion coefficient (D1) of the PF strand
FIGURE 8 Differences in the dynamics of APs and ionic currents
between the canine PF and ventricular cell models. Simulated AP morphol-
ogies and ionic current traces in the PF (left) and endocardial (right) cell
models are shown. (Upper left inset) Experimental AP recording from
a canine PF cell (25).(Fig. 13). Paradoxically, variations (primarily decrease) in
d1 that decrease v at the same time can increase SF, suggesting
that slower conduction through the PVJ corresponds to higher
safety (Fig. 13 A). However, the SF does not increase mono-
tonically: as d1 is decreased to<~1 mm, SF starts to decrease,
until it eventually drops below 1 and the AP conduction
through the PVJ fails. Hence, dependence of the SF on d1
has a maximum at d1 ¼ d1z1 mm, where d1 can be consid-
ered as an ‘‘optimal’’ width of the PF for the conditions
chosen. Note that PF bundles dissected from canine hearts
can be 0.5–2.0 mm in diameter (31,32). As v monotonically
increases with d1, dependence of the SF on v also has
a maximum at v ¼ v*z 0.3 m/s (Fig. 13 C), where v* can
be considered as an optimal velocity providing maximum
safety of conduction through the PVJ.
Dependence of the SF onD1 also exhibits a clear maximum
at D1 ¼ D1z0:6 mm2 ms1 (Fig. 13 B), and the respective
dependence of SF on v in this case has a maximum at v ¼
v* z 0.3 m/s (Fig. 13 C). Note that v in our simulation is
measured at the PVJ and, hence, is dependent on the gradient
between D1 and D2, rather than on either of the two diffusion
coefficients. Therefore, the simple relationship v  ﬃﬃﬃﬃDp (1)
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FIGURE 9 AP properties in the PF cell model. (A) Morphology compared
with experimental data (25). (B) Restitution curve compared with experi-
ment (27). APD90, AP duration at 90% repolarization.Biophysical Journal 97(1) 20–39
28 Aslanidi et al.valid for a uniform diffusion coefficient, D, does not apply
in this case, and v decreases as D1 is increased (Fig. 13 B).
Note also that the dependence of the SF on v has a maximum
in the tissue with only one nonuniform parameter (d1 ¼ d2,
A
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C
FIGURE 10 Properties of the two-dimensional slice model of the PVJ. (A)
Geometry of the PVJ. A single PF runs into a slab of ventricular tissue (gray)
that consists of endocardial, midmyocardial, and epicardial layers (20). The
width of the PF, d1, is much smaller than the width of the ventricular slab, d2.
(Insets) AP morphologies in the PF (left) and ventricular (right) cells. The
horizontal arrow shows the direction of AP propagation. (B) Plots of the
nonuniform diffusion coefficient, D, and the AP conduction time delay,
DT, at the PVJ, showing profiles of D (dashed line) and DT (solid line) along
the horizontal spatial coordinate, x. DT is measured over a distance of 2 mm
along the x-direction, as in experiments (29). (C) Time delay between APs
recorded from the PF and ventricular tissues 2 mm apart across the PVJ.
Biophysical Journal 97(1) 20–39D1 > D2), at the optimal velocity v ¼ v* z 0.45 m/s
(Fig. 13 C). These results demonstrate that both very fast
and very slow conduction can be unsafe, whereas there is an
optimal conduction velocity that produces the maximum
SF. It is noteworthy that the optimal velocities of conduction
through the PVJ, v*, lie within the physiological range of
experimentally observed AP conduction velocities.
3D wedge simulations
Considering the 3D structure of the ventricular wall, we
studied conduction through the PVJ with realistic
morphology using the 3D wedge model. Stimulation applied
to the free-running end of the PF strand resulted in AP conduc-
tion through the PVJ into the ventricular tissue (Fig. 14). As in
the 2D slice model, under physiological conditions (i.e., phys-
iologically relevant cellular AP properties, as well as experi-
mentally validated dimensions and intercellular couplings of
A
B
FIGURE 11 Discontinuous AP conduction through the PVJ, represented
by (A) time delay, DT, and (B) velocity, v. Plots show profiles of DT and
v along the horizontal spatial coordinate x. Four cases are illustrated:
the PVJ with nonuniformities in both tissue geometry and diffusion coeffi-
cient (d1 < d2, D1 > D2), tissue with a nonuniform diffusion coefficient
(d1 ¼ d2, D1 > D2), tissue with a nonuniform geometry (d1 < d2, D1 ¼ D2),
and tissue where both geometry and diffusion coefficient are uniform
(d1 ¼ d2, D1 ¼ D2).
Safety of Discontinuous Conduction 29the PF and ventricular tissues), conduction through the PVJ
was slowed down, demonstrating a significant time delay
(Fig. 14 A), a local decrease of the conduction velocity, v,
C
FIGURE 12 AP conduction in the 2D model of the PVJ, showing (A)
spatial distribution of the transmembrane potential, V (mV), during success-
ful AP conduction from the PF into the ventricular tissue, and (B) the resul-
tant distribution of SF. Color keys for spatial distributions are at right. (C)
Profile of the SF along the horizontal spatial coordinate, x.and an increase of the SF at the PVJ (Fig. 14B). With variation
of the diffusion coefficient of the PF strand, the relationships
between v and the SF showed similarity to those observed in
2D slices. Note that the varied parameter, D1, can be altered
experimentally, for example, by applying gap junction
blockers to the PF. Dependence of the SF on D1 had a
maximum at ~1.5 mm2/ms (Fig. 14 C), which is larger than
that in 2D slices due to the increased electrical load imposed
by the 3D mass of ventricular tissue. The correspond-
ing dependence of SF on v had a maximum at ~0.6 m/s
A
B
C
FIGURE 13 Relationships between nonuniformities of the PVJ, the AP
conduction velocity, v, and the safety factor, SF. (A and B) Dependence of
v and SF on width of the PF, d1 (A), and on the diffusion coefficient of
the PF, D1 (B). Both velocity and SF were measured at the PVJ, where v
reached a local minimum. (C) Relationships between v and SF at the PVJ.
Three cases are illustrated: v is changed by varying d1, v is changed by
varying D1 at the PVJ (d1 < d2), and v is changed by varying D1 in a geomet-
rically uniform tissue (d1 ¼ d2). In all three cases, the dependence of the SF
on v has a maximum.Biophysical Journal 97(1) 20–39
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A
B
FIGURE 14 AP conduction in the 3D
model of the PVJ. (A) Spatial distribution
of the time delay, DT, during successful
AP conduction from the PF into the
ventricular wedge. (B) Resultant distri-
bution of the SF. Spatial distributions
are color-coded as shown at right. Note
that the visible discontinuity of the 3D
patterns is due to the anisotropy of the
ventricular tissue. (C) Dependence of v
and SF on the diffusion coefficient of
the PF, D1. Both velocity and SF were
measured at the PVJ, where v reached
a local minimum. (D) Relationship
between v and SF at the PVJ. As in
Fig. 12 C, the dependence of the SF on
v has a maximum.(Fig. 14 D), which also fits well into the range of experimen-
tally observed AP conduction velocities (28,29). Hence,
results obtained with a simple 2D slice model have been
qualitatively validated and qualitatively reevaluated by using
the morphologically detailed 3D model.
Note that quantitative differences between 2D and 3D
simulations (Fig. 13 and 14) are due to different source-
to-sink relations in the two models, as the same set of param-
eters were used for both cases. Adding the third dimension
increases the mass of ventricular tissue—the sink—much
more substantially than the mass of the PF—the source,
which leads to quantitative (but not qualitative) differences.
Thus, an optimal conduction velocity exists in both 2D and
3D, assuming values of ~0.3 m/s and ~0.6 m/s, respec-
tively—both values have the same order of magnitude and
fall within the experimentally reported range of conduction
velocities through the PVJ. The higher optimal velocity in
3D may be explained by the fact that conduction into a large
3D mass of ventricular tissue requires faster transfer of
charge though the PVJ to maintain the same level of safety
as in 2D slices.
DISCUSSION
We have developed a morphologically and electrophysiolog-
ically detailed model of the PVJ to determine relationships
between its heterogeneity parameters and the velocity and
safety of AP conduction through it. Simulations with the
model demonstrated that when the tissue dimensions and
the intercellular electrical coupling at the PVJ are varied,
neither very fast nor very slow conduction is safe, and there
exists an optimal velocity that provides the maximum safety
factor for conduction through the junction. The respective
conduction time delay across the PVJ occurs as a natural
consequence of the electrophysiological and morphological
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the much larger ventricle imposes a large electrical load on
the PF, which in combination with the disparity in electro-
tonic intercellular coupling leads to delays in conduction
through the junction. Below, we discuss major achieve-
ments, as well as limitations, of the study, and compare
our results and conclusions with mechanisms of discontin-
uous conduction in heterogeneous cardiac tissues reported
in other studies.
Single-cell model
A new electrophysiologically detailed model describing AP
properties in a canine PF cell has been developed based on
modifications of the canine ventricular cell model (20). To
our knowledge, this is the first species-specific mathematical
model to incorporate extensive experimental data on ionic
channel properties (21,24) and produce experimentally vali-
dated AP morphologies (25) and rate dependence (27) for
a mammalian (primarily canine) PF cell.
Early development of single-cell cardiac models, such as
the iconic DiFrancesco-Noble model (33), which integrates
electrophysiological descriptions of ionic channels with a
description of the ionic pump and sequestering process,
provided a very general description for a mammalian PF
cell. In the past two decades, the emphasis has shifted from
such general models to species-specific models developed
for a variety of human or animal cardiac tissue types, including
the sinoatrial node, atria, and ventricles, whereas PFs have
been largely neglected. However, achieving the ultimate
goal of creating a virtual heart will require detailed models
of all parts of the cardiac conduction system, including the PF.
The developed PF cell model was validated by its ability
to reproduce experimental data for the kinetics of several
major ionic currents recorded from a single species (21,24),
Safety of Discontinuous Conduction 31which included INa,L, ICa,L, ICa,T, Ito, IK,r, IK,s, and IK,1 from
canine PF cells. Kinetic variables, time courses, and I/V rela-
tionships for each of these currents were fitted to the experi-
mental data (Figs. 1–6). The PF cell model equations and
parameters used were also validated by the simulated AP char-
acteristics matching experimental data (21,25,27) in the
resting potential, AP overshoot, maximum upstroke velocity,
low AP plateau, and long AP duration. Of most importance,
the model was able to reproduce experimental data on the
AP rate dependence (27) in a canine PF cell (Fig. 9). Large
differences in ionic currents such as INa,L, IK,r, and IK,1 between
the canine PF and ventricular cells (Figs. 7 and 8) contribute to
major differences in the AP morphologies observed experi-
mentally between these two cardiac cell types (25).
Limitations
Limitations of cardiac cell and tissue models are well docu-
mented (2,20). In our single PF cell model development, we
modified the equations for all major ionic currents (INa, INa,L,
ICa,L, ICa,T, Ito, IK,1, IK,r, and IK,s) in the ventricular cell model
(20) based on available experimental data (21,24). However,
the hyperpolarization-activated pacemaking current, If, was
not introduced in the PF model, as no experimental data on
its properties in canine PF cells were available. Note only
that under physiological conditions, canine PFs do not
show pacemaking. Besides, for pump and exchanger
currents, as well as intracellular Ca2þ handling, due to the
lack of experimental data concerning differences between
the PF and ventricular cells, we used equations and parame-
ters from the original ventricular model (20) and assumed no
difference between these two cell types. Note also that in the
3D anatomical tissue model, the PF was considered to run
perpendicular to the endocardial surface of the left ventric-
ular wall, whereas spatial interactions between PFs and
ventricular tissue in vivo can be complex (14).
Late Naþ current
Due to lack of experimental data, our formulation for INa,L
was based on a single data source (24), which may limit
the validity of the model properties related to this current.
The quality of the experimental data (24) is also arguable,
as Naþ currents were measured without blockade of Kþ
currents; besides, the effective patch pipette resistance was
large (5–8 MU) and the recording temperature was not spec-
ified. However, in the absence of other data sources for
canine PFs, it is reasonable to use the data (24) as the basis
for INa,L formulation based on the following arguments. 1),
Although Kþ currents were not blocked, pharmacological
evidence from the same study (24) shows that the total
current was almost completely blocked by tetrodotoxin
(TTX) or lignocaine and hence was predominantly Naþ
current. 2), In a more recent study from the same group
(34), which showed similar results, the recording tempera-
ture was explicitly specified as 37C. 3), Large pipette resis-tance,R ~ 5–8 MU, could present a major problem in measure-
ments of a very large fast Naþ current, INa, but for the much
smaller late sodium current, INa,L, which reaches the maximum
amplitude of I ~300 pA at20 mV, such a resistance would
result in a maximum error of voltage measurement of approx-
imately IR¼ 300 pA  8 MU¼ 2.4 mV. In addition, record-
ings from PF strands (35) have shown INa,L with a density of
the same magnitude (~5 pA/pF), which is several times higher
than the respective current density in canine ventricular cells
(36,37). These arguments justify the use of experimental
data (24) for INa,L in our canine PF cell model.
There is experimental evidence for a prominent role of
high INa,L in the PFs. Thus, the APD in PFs is much longer
than in ventricular myocytes: this difference is related to
INa,L, as TTX shortens the AP of PFs much more than that
of ventricular myocytes (22,23); the latter study also shows
that TTX decreases intracellular sodium activity much more
in PF than in ventricular myocytes. Dose dependence of
INa,L on TTX shows that the current is blocked by ~50%
at TTX concentrations of ~106 M; such concentrations
have been used in experiments (22), producing a remarkable
decrease of the APD in PFs. In our model, a similar 50%
block of INa,L results in a twofold APD decrease, matching
the experimental data (22). However, a 50% block of INa,L
in ventricular cell models results in a much smaller APD
decrease, which is also consistent with experimental obser-
vations (22,36). This provides additional validation for the
INa,L characteristics used in our model.
Conduction time delay
Our simulations, in line with results of earlier theoretical and
experimental studies (4–8), show that the AP conduction
time delay across the PVJ occurs as a natural consequence of
the electrophysiological and morphological differences
between the PF and ventricular tissue. At the ionic level, the
delay allows the cell to accumulate a large amount of charge,
provided by the membrane currents, before passing it through
the PVJ for successful excitation of the ventricular tissue. At the
same time, the time delay enhances the source/load mismatch at
the PVJ over time. However, at optimal velocities, such
enhancement should be minimal, allowing safer conduction.
Indeed, according to Eq. 2, successful conduction requires
that the sum of integral currents produced (Iout) and stored (Ic)
by a cell must equal or exceed the current received from other
cells (Iin). Structural nonuniformities, such as changes in
tissue dimensions or heterogeneities of gap junctional
coupling, can create electrical imbalance between these
currents and, hence, influence the conduction safety. Thus,
an abrupt increase of the tissue dimensions at the PVJ (d1 <
d2) means that a larger load imposed by the mass of ventricular
tissue decreases the current density of Iout in comparison to Iin.
On the other hand, a decrease of the intercellular coupling
(D1 > D2) reduces electrical loading at the PVJ; as a result,
less current leaks into the ventricular tissue at any given
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ionic current (Iion) is stored by the cell. Long conduction
time delays (Fig. 11 A) allow more charge to be stored and
then passed through the PVJ over time. Hence, when both
nonuniformities are combined (d1 < d2, D1 > D2), source/
load mismatch at the PVJ coexists with increase of the total
stored/passed currents due to long conduction time delays.
The balance between these two processes determines whether
the SF increases or decreases when d1 or D1 are varied.
In a similar way, when the conduction velocity, v, at the
PVJ is too low, the resultant time delay is long enough for
a substantial amount of capacitive charge to be stored, but
also long enough to enhance the mismatch between Iin and
Iout at the PVJ over time. When v is too high and the time
delay is short, imbalance between Iin and Iout is not enhanced,
but cells at the PVJ cannot accumulate sufficient charge at
their capacity. Thus, in both cases the conduction is unsafe,
and there must be an optimal conduction velocity and an
optimal time delay sufficient for the tissue to accumulate
and pass through the PVJ substantial charge, but not long
enough to let the mismatch between Iin and Iout at the junc-
tion be substantially enhanced over time.
Note that the L-type Ca2þ current, ICa,L, has been identi-
fied as the major inward current sustaining discontinuous
AP conduction (3,38–40). Hence, the conduction time delay,
DT, may be essential in providing enough time for ICa,L to
become activated. At the same time, ICa,L produces signifi-
cant effects on the membrane potential and the intracellular
Ca2þ concentration (40) and hence may alter AP conduction
properties, primarily DT, at the PVJ. Finding detailed ionic
mechanisms of the feedback between ICa,L and DT at the
PVJ presents an interesting challenge for a separate study,
but is beyond the scope of this work.
Optimal velocity
Our simulations show the existence of an optimal velocity that
provides the maximum conduction safety through the hetero-
geneous PVJ (Figs. 13 and 14). Simulations with a uniform
one-dimensional cardiac tissue (3) suggest that the depen-
dence of SF on the conduction velocity can also have
a maximum at very slow velocities. Primarily, SF has mono-
tonically increased when a uniform diffusion coefficient (D)
in a one-dimensional tissue was decreased to very low values,
and dropped abruptly only as D approached zero and the
conduction velocity, v  ﬃﬃﬃﬃDp , reached a nonphysiologically
low value of ~0.02 m/s (3). However, the following simple
theoretical analysis demonstrates that such a maximum
in a uniform tissue is not feasible, and hence can present an
artifact of numerical approximation.
As Ic ¼ vV / vt, Iin ¼ DVV and Iout ¼ DVVþ (where
VV and VVþ are voltage gradients between a cell and its
upstream and downstream neighbors, respectively, and all
currents are normalized by the membrane capacitance, Cm),
Eq. 2 can be written as
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A
VVþ dt
D R
A
VVdt
¼ a þ bD
cD
; (3)
where a> 0 corresponds to the positive AP amplitude, b> 0
and c> 0 are positive integrals at the wave front where VR
V R Vþ, and both gradients, VVzðV  VÞ=Dx and
VVþzðVþ  VÞ=Dx, are always negative. From Eq. 3, it is
clear that SF / N when D / 0, and the derivative
vSF=vD ¼ a=cD2 < 0 is negative for all values D > 0;
hence, SF(D) is a monotonically decreasing function. Only
at a singular point D¼ 0, cells in the tissue are not connected
to each other, AP conduction fails (v ¼ 0 and SF < 1). Thus,
SF(D) in a uniform tissue cannot have a maximum at small,
but nonzero, values of D (and hence, v  ﬃﬃﬃﬃDp ). The previ-
ously reported ‘‘maximum’’ (3) could be due to numerical
approximation errors during solving Eq. 1 or calculating
Eq. 2. Our simulations of a uniform one-dimensional ventric-
ular strand corroborate this: the maximum in the SF(D) depen-
dence progressively shifts toward infinity when the space step
of numerical integration, Dx, is decreased, and completely
disappears forDx< 0.003 mm; SF(D) calculated with smaller
Dx is monotonic (not shown).
However, for nonuniform tissues, SF is not a monotonic
function of D. In this case,
SF ¼ a þ bðD1  DDÞ
cD1
;
vSF
vD1
¼ bDD a
cD2
; (4)
where DDhD1  D2 is the difference in diffusion coeffi-
cients between the PF and ventricles. vSF=vD1 ¼ 0 when
DD ¼ a=b, and hence, dependence of the SF on the diffusion
coefficient of the PF, D1, has an optimum. Note that this
holds not only for the nonuniform PVJ, but for any tissue
with a nonuniform diffusion coefficient.
It is also possible that the previous study (3) actually im-
plemented a nonuniform model with differential coupling
within and between cells (see description in the Appendix
of that article), as it is not explicitly stated which model
they used in simulations showing the existence of a maximum
SF. If so, the relationship shown between SF and D fits into
our theoretical analysis. Thus, the study presented here not
only predicts an optimal conduction velocity for a specific
PVJ model, but also provides theoretical insights into the
existence of such an optimum in nonuniform tissues and its
infeasibility in uniform tissues.
Application to other tissues
Equation 1 belongs to a broad class of nonlinear reaction-diffu-
sion equations that describe wave propagation in many excit-
able biological systems (1), where phenomena similar to those
described in our article can exist. For example, discontinuous
propagation through nonuniform junctions has been demon-
strated in branching fibers of the atrioventricular node (7),
infarcted ventricular tissues (15,16), and neural dendritic trees
Safety of Discontinuous Conduction 33(41), and has also been associated with breakdown of propa-
gating wave fronts during development of atrial fibrillation
(42). Finding simple phenomenological relationships between
the wave velocity and conduction safety indicators can provide
new theoretical and practical insights into optimal conditions
for wave propagation in such complex heterogeneous systems.
APPENDIX: CANINE PF CELL MODEL EQUATIONS
General equations
dV
dt
¼ ðIion þ IstimÞ
Cm
Itot ¼ INa þ INa;l þ ICa;L þ ICa;T þ Ito;1 þ Ito;2 þ IK;r
þ IK;s þ IK1 þ INaCa þ INaK þ INa;b þ IK;b
þ ICa;b þ ICl;b þ ICa;p þ IK;p
Fast Naþ current
INa ¼ gNam3ð0:8h þ 0:2jÞðV  ENaÞ
dm
dt
¼ mN  m
tm
mN ¼ am
am þ bm
; tm ¼ 1:0
am þ bm
am ¼ 0:32ðV þ 47:13Þ
1  e0:1ðVþ 47:13Þ ; bm ¼ 0:08e
V=11:0
dh
dt
¼ hN  h
th
hN ¼ ah
ah þ bh
; th ¼ 1:0
ah þ bh
if ðV < 40mVÞ; ah ¼ 0:135eðVþ 80:0Þ=6:8;
bh ¼ 3:56e0:079V þ 310; 000e0:35V ;
otherwise; ah ¼ 0:0; bh ¼
1:0
0:13ð1 þ eðVþ 10:66Þ=11:1Þ
dj
dt
¼ jN  j
tj
jN ¼ 0:1aj
aj þ bj
; tj ¼ 0:1
aj þ bj
if ðV < 40mVÞ;
aj ¼ ð127140e
0:2444V þ 0:00003474e0:04391VÞðV þ 37:78Þ
1 þ e0:311ðVþ79:23Þ
bj ¼
0:1212e0:01052V
1 þ e0:1378ðVþ 40:14Þ;
otherwise; aj ¼ 0:0; bj ¼
0:3e0:000000235V
1 þ e0:1ðVþ 32Þ:
Late Naþ current
INa;L ¼ gNa;Lm3LhLðV  ENaÞ
dmL
dt
¼ mL;N  mL
tmL
mL;N ¼ amL
amL þ bmL
; tmL ¼
1:0
amL þ bmL
amL ¼
0:32ðV þ 47:13Þ
1  e0:1ðVþ 47:13Þ ; bmL ¼ 0:08e
V=11:0
dhL
dt
¼ hN;L  hL
thL
hN;L ¼ 1:0
1 þ eVþ 69=6:1; thL ¼ 175 þ
125
1 þ eðVþ 25Þ=6
L-type Ca2þ current
ICa;L ¼ gCa;Ldff2fCafCa;2iCa
iCa ¼ pCaz2Ca
ðV  15ÞF2
RT
gCai

Ca2þ

r
ezCaFðV15Þ=RT  gCao

Ca2þ

o
ezCaFðV15Þ=RT  1
dd
dt
¼ dN  d
td
dN ¼ 1:0
1 þ eðV4Þ=6:74; td ¼ 0:59 þ
0:8e0:052ðV þ 13Þ
1 þ e0:132ðVþ 13Þ
df
dt
¼ fN  f
tf
fN ¼ 1:0
1 þ eðV þ 18Þ=10; tf ¼ 4 þ 0:005

V  2:5Þ2
df2
dt
¼ f2;N  f2
tf2
f2;N ¼ 1:0
1 þ eðVþ 18Þ=10; tf2 ¼ 38 þ 0:07

V  18:6Þ2
dfCa
dt
¼ fCa;N  fCa
tCa
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1  ICa;L=0:05 þ
0:55
1 þ ½Ca2þ r=0:003
þ 0:15
tfCa ¼ 0:5 þ
10:0CaMK;act
CaMK;act þ km;Ca;MK þ
1:0
1:0 þ ½Ca2þ r=0:003
dfCa;2
dt
¼ fCa;2;N  fCa;2
tfCa;2
fCa;2;N ¼ 1:0
1  ICa;L=0:01;
tfCa;2 ¼ 125 þ 3001þeðICa;Lþ0:175Þ=0:04
T-type Ca2þ current
ICa;T ¼ gCa;TbgðV  ECa;TÞ
db
dt
¼ bN  b
tb
bN ¼ 1:0
1 þ eðVþ 33Þ=6:1; tb ¼
1:0
ab þ bb
ab ¼ 1:068eðVþ 16:3Þ=30; bb ¼ 1:068eðVþ 16:3Þ=30
dg
dt
¼ gN  g
tg
gN ¼ 1:0
1 þ eðVþ 60:0Þ=6:6; tg ¼
1:0
ag þ bg
ag ¼ 0:015eðVþ 71:7Þ=83:3; bg ¼ 0:015eðVþ 71:7Þ=15:4
Transient outward Kþ current
Ito;1 ¼ gto;1að0:8i þ 0:2i2ÞðV  EKÞ
da
dt
¼ aN  a
ta
aN ¼ aa
aa þ ba
; ta ¼ 1:0
aa þ ba
aa ¼ 25 e
ðV76Þ=20
1 þ eðV76Þ=20; ba ¼ 25
eðVþ 54Þ=20
1 þ eðVþ 54Þ=20
di
dt
¼ iN  i
ti
iN ¼ ai
ai þ bi
; ti ¼ 6 þ 5
1 þ eðV16:5Þ=10
ai ¼ 0:03
1 þ eðVþ 25Þ=15; bi ¼ 0:1
eðV40Þ=15
1 þ eðV40Þ=15
di2
dt
¼ i2;N  i2
ti2
i2;N ¼ ai2
ai2 þ bi2
; ti2 ¼ 21:5 þ
30
1 þ eðV25Þ=10
ai2 ¼
0:00442
1 þ eðVþ 26Þ=15; bi2 ¼ 0:05
eðV10Þ=15
1 þ eðV10Þ=15
Fast delayed rectiﬁer Kþ current
IK;r ¼ gK;rxrrr;NðV  EKÞ
gK;r ¼ 0:040008488
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
½Kþ o
5:4
s
rr;N ¼ 1:0
1 þ eðV5:4Þ=20:4
dxr
dt
¼ xr;N  xr
txr
xr;N ¼ 1:0
1 þ eðVþ 0:085Þ=12:25; txr ¼
900
1 þ eV=5 þ 100
Slow delayed rectiﬁer Kþ current
IK;s ¼ gK;sxs;1xs;2ðV  EK;sÞ
gK;s ¼ 0:052581329
 
1 þ 0:6
1 þ 0:000038=Ca2þ 
i
1:4
!
dxs;1
dt
¼ xs;N  xs;1
txs;1
;
dxs;2
dt
¼ xs;N  xs;2
txs;2
xs;N ¼ 1:0
1 þ eðV9Þ=13:7;
txs;1 ¼

0:0000761ðV þ 44:6Þ
1  e9:97ðVþ 44:6Þ þ
0:00036ðV  0:55Þ
e0:128ðV0:55Þ  1
1
;
txs;2 ¼ 2txs;1
Inward rectiﬁer Kþ current
IK;1 ¼

gK;1xK;1 þ 0:004
ðV  EKÞ
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ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
½Kþ o
5:4
s
xK;1 ¼ aK;1
aK;1 þ bK;1
aK;1 ¼ 1:02
1 þ e0:2385ðVEK59:215Þ;
bK;1 ¼
0:49124e0:08032ðVEK þ 5:476Þ þ e0:06175ðVEK594:31Þ
1 þ e0:5143ðVEK þ 4:753Þ
Plateau Kþ current
IK;p ¼ gK;pkpðV  EKÞ
kp ¼ 1:0
1 þ eð7:488VÞ=5:98
Ca2þ-dependent transient outward Cl current
Ito;2 ¼ 20ito;2a
ito;2 ¼ pClz2Cl
VF2
RT

Cli  ½CloezClVF=RT
1  e-zClVF=RT
da
dt
¼ aN  a
ta
aN ¼ 1:0
1 þ km;to;2=

Ca2þ r
; ta ¼ 1:0
Naþ-Ca2þ exchanger current
dNaCa;1 ¼ km;Cao

Naþ 3i þ 1:5k3m;Nao

Ca2þ i
þ k3m;Nai ;1

Ca2þ o

1 þ 1:5½Ca2þ i=km;Cai

dNaCa;2 ¼ km;Cai ½Naþ 3o
	
1 þ Naþ i=km;Nai;13

þ ½Naþ 3i ½Ca2þ o þ 1:5½Naþ 3o½Ca2þ i
Naþ-Kþ pump current
INaK ¼ gNaKfNaK 1:0
1 þ km;Nai ;2=Naþ i2
½Kþ o½Kþ o þ km;Ko
fNaK ¼ 1:0
1 þ 0:1245e0:1VF=RT þ 0:0365seVF=RT ;
s ¼ 1
7

e½Na
þ o=67:3  1
Ca2þ pump current
ICa;p ¼ ICa;p

Ca2þ

i
Ca2þ

i
þ km;Ca;p
Kþ-Cl cotransporter
CTK-Cl ¼ CTK-ClðEK  EClÞðEK  ECl þ 87:8251Þ
Naþ-Cl cotransporter
CTNa-Cl ¼ CTNa-Cl
ðENa  EClÞ4
ðENa  EClÞ4 þ 87:82514
Background currents
INa;b ¼ gNa;bðV  ENaÞ; IK;b ¼ gK;bðV  EKÞ;
ICl;b ¼ gCl;bðV  EClÞ
ICa;b ¼ pCa;bz2Ca
VF2
RT
gCai ½Ca2þ iezCaVF=RT  gCao ½Ca2þ o
ezCaVF=RT  1
Equilibrium potentials
ENa ¼ RT
F
ln

Naþ

o
Naþ

i
; EK ¼ RT
F
ln

Kþ

o
Kþ

i
;
ECa ¼ RT
2F
ln

Ca2þ

o
Ca2þ

i
; ECl ¼ RT
F
ln

Cl

o
Cl

i
;
EK;s ¼ RT
F
ln
 
½Kþ o þ rNaK½Naþ o
½Kþ i þ rNaK½Naþ i
!
INaCa ¼ XNaCaiNaCa;max½Na
þ 3i ½Ca2þ oe 1:5½Naþ 3o½Ca2þ ie0:65VF=RT	
1 þ km;Ca;ct=1:5½Ca2þ i2
ð1 þ ksate0:65VF=RTÞðdNaCa;1 þ dNaCa;2Þ
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d½Naþ i
dt
¼ ðINa þ INa;l þ INa;b þ 3INaK þ 3INaCaÞacap
VolmyoF
þ CTNa-Cl
d½Cli
dt
¼ ðIto;2 þ ICl;bÞacap
VolmyoF
þ CTNa-Cl þ CTK-Cl
Intracellular Ca2þ concentration
d½Ca2þ i
dt
¼ 

ICa;b þ ICa;p  2INaCa

acap
2VolmyoF
þ qup  qleakVolnsr
Volmyo
 qdiff Volss
Volmyo
dmyo ¼ km;TRPNkm;CMDN½Ca2þ tot
cmyo ¼ km;CMDNkm;TRPN  ½Ca2þ totðkm;TRPN þ km;CMDNÞ
þ TRPN  km;CMDN þ CMDN  km;TRPN
bmyo ¼ CMDN þ TRPN  ½Ca2þ tot þ km;TRPN
þ km;CMDN
½Ca2þ tot ¼ TRPN þ CMDN þ d½Ca2þ i þ ½Ca2þ i
CMDN ¼ CMDN
 
½Ca2þ i
½Ca2þ i þ km;CMDN
!
TRPN ¼ TRPN
 
½Ca2þ i
½Ca2þ i þ km;TRPN
!
Ca2þ/calmodulin-dependent protein kinase
CaMK;act ¼ CaMK;bound þ CaMK;trap
dCaMK;trap
dt
¼ aCa;MKCaMK;bound

CaMK;bound þ CaMK;trap

 bCa;MKCaMK;trap
CaMK;bound ¼
CaMK;0

1  CaMK;trap

1 þ km;Ca;MK=½Ca2þ r
NSR Ca2þ concentration
d½Ca2þ NSR
dt
¼ qup  qleak  qtr VolJSR
VolNSR
JSR Ca2þ concentration
d

Ca2þ

JSR
dt
¼ qtr  qrel
1 þ CSQNkm;CSQN=

km;CSQN þ ½Ca2þ JSR
2
Restricted-space Ca2þ concentration
½Ca2þ r ¼
2
3
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
b21  3c1
q
cos

 
1
3
arccos
 
9b1c1  2b31  27d1
2

b21  3c1
1:5
!!
 b1
3
d1 ¼ km;b;SRkm;b;SL

Ca2þ

r;tot
c1 ¼ km;b;SRkm;b;SL 

Ca2þ

r;tot
ðkm;b;SR þ km;b;SLÞ
þ bSRkm;b;SL þ bSLkm;b;SR
b1 ¼ bSR þ bSL 

Ca2þ

r;tot
þ km;b;SR þ km;b;SL

Ca2þ

r;tot
¼ Ca2þ 
r
þ bSR þ bSL þ d

Ca2þ

r
½Ca2þ i ¼
2
3
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
b2myo  3cmyo
q
cos
 
1
3
arccos
 
9bmyocmyo  2b3myo  27dmyo
2
	
b2myo  3cmyo

1:5
!!
 bmyo
3
d½Kþ i
dt
¼ 

Ito;1 þ IK1 þ IK;r þ IK;s þ IK;p þ IK;b  2INaK

acap
VolmyoF
þ CTK-Cl
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 
Ca2þ

r
Ca2þ

r
þ km;b;SL

;
bSR ¼ bSR
 
Ca2þ

r
Ca2þ

r
þ km;b;SR

d

Ca2þ

r
dt
¼  ICa;Lacap
VolsszCaF
þ qrelVolJSR
Volss


Ca2þ

r
Ca2þ 
i
tss
SR release ﬂux
qrel ¼ grelrori
½Ca2þ JSR  ½Ca2þ r
grel ¼ 3000vg; vg ¼ 1:0
1 þ eðgCa;LiCa þ 13Þ=5
dri
dt
¼ ri;N  ri
tri
ri;N ¼ 1:0
1 þ eð½Ca2þ r0:0004þ 0:002CafacÞ=0:000025
;
tri ¼
350  tCa;MK
1 þ eð½Ca2þ r0:003þ 0:003CafacÞ=0:0002
þ 3:0 þ tCa;MK
Cafac ¼ 1:0
1 þ eðICa;L þ 0:05Þ=0:015
;
tCa;MK ¼ tCa;MK CaMK;act
km;Ca;MK þ CaMK;act
dro
dt
¼ ro;N  ro
tro
ro;N ¼ ro;N;JSR
I2Ca;L
I2Ca;L þ 1
ro;N;JSR¼

Ca2þ
1:9
JSR
Ca2þ
1:9
JSR
þ49:28Ca2þ
r
=

Ca2þ

r
þ 0:00281:9
SR leak ﬂux
qleak ¼ qleak½Ca
2þ NSR
NSR
SR uptake ﬂux
qup ¼ Xqup

dqup;Ca;MK þ 1

qup
½Ca2þ i
½Ca2þ i þ km;up  dkm;plb
dqup;Ca;MK ¼ dqup;Ca;MK CaMK;act
km;Ca;MK þ CaMK;act
dkm;plb ¼ dkm;plb CaMK;act
km;Ca;MK þ CaMK;act
SR transfer ﬂux
qtr ¼ ½Ca
2þ NSR  ½Ca2þ JSR
ttr
Parameter values and initial values for all equations are listed in Tables 2
and 3.
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TABLE 2 Model parameter values
R 8314 J/kmol K
F 96487 C/mol
T 310 K
[Naþ]o 140 mM
[Ca2þ]o 1.8 mM
[Kþ]o 5.4 mM
[Cl-]o 100 mM
zNa 1
zK 1
zCa 2
zCl 1
gNai 0.75
gNao 0.75
gKi 0.75
gKo 0.75
gCai 1.0
gCao 0.341
gNa 8.0 pA/pF
gNa,L 0.037375 pA/pF
pCa 0.000243 cm/s
gCa,L 0.3392328 pA/pF
gCa,T 0.13 pA/pF
pCa,b 1.995084  107 cm/s
gto,1 0.14135944 pA/pF
rNaK 0.01833
gK,p 0.00276 pA/pF
km,to,2 0.1502 mM
pCl 0.0000004 cm/s
gCl,b 0.000225 pA/pF
XNaCa 0.4
iNaCa,max 4.5 pA/pF
km,Ca,act 0.000125 mM
km,Nai,1 12.3 mM
km,Nao 87.5 mM
km,Cai 0.0036 mM
km,Cao 1.3 mM
ksat 0.27
gNaK 0.61875 pA/pF
km,Nai,2 10 mM
km,Ko 1.5 mM
ip,Ca 0.0575 pA/pF
(Continued)
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38 Aslanidi et al.TABLE 2 (Continued)
km,p,Ca 0.0005 mM
CTK-Cl 7.0756  106 mM/ms
CTNa-Cl 9.8443  106 mM/ms
tr,o 3.0 ms
qleak 0.004375 mM/ms
NSR 15.0 mM
Xqup 0.5
dqup;Ca;MK 0.75
dkm,plb 0.00017
km,up 0.00092 mM
qup 0.004375 mM/ms
ttr 120.0 ms
bSR 0.047 mM
km,b,SR 0.00087 mM
bSL 1.124 mM
km,b,SL 0.0087 mM
tss 0.2 ms
CSQN 10.0 mM
km,CSQN 0.8 mM
CMDN 0.05 mM
km,CMDN 0.00238 mM
TRPN 0.07 mM
km,TRPN 0.0005 mM
CaMK,0 0.05
aCa,MK 0.05/ms
bCa,MK 0.00068/ms
km,Ca,MK 0.15
TABLE 3 Initial values
V 86.9351482
m 0.00111859
h 0.990199813
j 0.993630289
d 0.00000138
f 0.999967371
f2 0.999964108
fCa 0.985118263
fCa,2 1.0
b 0.000087458
g 0.989496155
xs1 0.018988645
xs2 0.018988645
xr 0.000000014
a 0.01303108
i 0.999972058
i2 0.999813749
aa 0.000555155
mL 0.00111859
hL 0.339310414
ri 0.999950186
ro 0.0
[Ca2þ]r 0.0000834
[Ca2þ]JSR 1.27169598
[Ca2þ]NSR 1.271695903
[Naþ]i 9.875593321
[Kþ]i 142.0142622
[Cl]i 18.90029866
[Ca2þ]i 0.0000834
CaMK,act 0.003264868
CaMK,trap 0.000632046
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